Company / Working Capital per Share
West Pharmaceutical Services Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$18.30
FY2025
5-year range
$13.44 / $18.87
FY2021-FY2025
Trend
+36.2%
vs FY2024
Sector context
#19 of 158
Health Care
What the data says
West Pharmaceutical Services's working capital per share of $18.30 is higher than 88% of companies in the Health Care sector (FY2025). Working Capital per Share returned to growth in FY2025 after 2 years of decline, reaching $18.30.
Based on SEC 10-K filings.
18.30 in FY2025 with a 5-year CAGR of +9.3%. Top quartile in the Health Care sector.
Improved from $17.07 to $18.30 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- +9.3%
- 10-Year CAGR
- -
Sector benchmark
-25.1% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 36.2% year-over-year.
- Ranks #19 out of 158 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.30 | +36.2% |
| FY2024 | $13.44 | -21.3% |
| FY2023 | $17.07 | -9.6% |
| FY2022 | $18.87 | +21.7% |
| FY2021 | $15.51 | +32.1% |
| FY2020 | $11.74 | +21.4% |
| FY2019 | $9.68 | +17.1% |
| FY2018 | $8.26 | +30.2% |
| FY2017 | $6.35 | +14.5% |
| FY2016 | $5.54 | +10.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026